Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-30,000
Closed -$771K 8013
2018
Q4
$771K Hold
30,000
﹤0.01% 3908
2018
Q3
$1.29M Hold
30,000
﹤0.01% 3611
2018
Q2
$1.3M Hold
30,000
﹤0.01% 3551
2018
Q1
$1.1M Hold
30,000
﹤0.01% 3631
2017
Q4
$1.08M Hold
30,000
﹤0.01% 3721
2017
Q3
$1.07M Hold
30,000
﹤0.01% 3650
2017
Q2
$988K Buy
+30,000
New +$1.04M ﹤0.01% 3627
2016
Q1
Sell
-199,900
Closed -$6.7M 7992
2015
Q4
$6.7M Sell
199,900
-25,000
-11% -$929K ﹤0.01% 1723
2015
Q3
$8.47M Buy
224,900
+134,800
+150% +$5.51M 0.01% 1519
2015
Q2
$4.35M Sell
90,100
-62,500
-41% -$3.21M ﹤0.01% 2217
2015
Q1
$7.63M Sell
152,600
-1,427,000
-90% -$77.4M 0.01% 1695
2014
Q4
$104M Buy
+1,579,600
New +$110M 0.07% 285

Other funds holding NOV

UBS Group's NOV Position: Q1 2026 in Review

UBS Group increased its NOV (NOV) stake by 75% in Q1 2026, buying an estimated $8.65M and bringing the position to 1,071,803 shares worth $20.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2575.

UBS Group first reported a position in NOV in Q4 2014 and has held it in 46 quarters since. The position peaked at $104M in Q4 2014. 464 funds tracked by Wall St. Rank hold NOV as of Q1 2026.

  • UBS Group held 1,071,803 shares of NOV worth $20.2M as of Q1 2026.
  • UBS Group bought 460,678 NOV shares in Q1 2026, an estimated $8.65M.
  • NOV made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2575 holding.
  • UBS Group first reported a position in NOV in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's NOV position peaked at $104M in Q4 2014.
  • 464 funds tracked by Wall St. Rank held NOV as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.